SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-17-003310
Filing Date
2017-12-14
Accepted
2017-12-14 16:48:52
Documents
58
Period of Report
2017-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pharmacyte_10q-103117.htm 10-Q 354557
2 CERTIFICATION pharmacyte_ex3101.htm EX-31.1 8578
3 CERTIFICATION pharmacyte_ex3102.htm EX-31.2 8605
4 CERTIFICATION pharmacyte_ex3201.htm EX-32.1 4164
5 CERTIFICATION pharmacyte_ex3202.htm EX-32.2 4304
  Complete submission text file 0001683168-17-003310.txt   2901440

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pmcb-20171031.xml EX-101.INS 595960
7 XBRL SCHEMA FILE pmcb-20171031.xsd EX-101.SCH 32917
8 XBRL CALCULATION FILE pmcb-20171031_cal.xml EX-101.CAL 37930
9 XBRL DEFINITION FILE pmcb-20171031_def.xml EX-101.DEF 146488
10 XBRL LABEL FILE pmcb-20171031_lab.xml EX-101.LAB 234828
11 XBRL PRESENTATION FILE pmcb-20171031_pre.xml EX-101.PRE 210546
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 333-68008 | Film No.: 171256665
SIC: 2833 Medicinal Chemicals & Botanical Products